Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

944 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PCSK9 inhibitors for treating hypercholesterolemia.
Pasta A, Cremonini AL, Pisciotta L, Buscaglia A, Porto I, Barra F, Ferrero S, Brunelli C, Rosa GM. Pasta A, et al. Among authors: ferrero s. Expert Opin Pharmacother. 2020 Feb;21(3):353-363. doi: 10.1080/14656566.2019.1702970. Epub 2020 Jan 1. Expert Opin Pharmacother. 2020. PMID: 31893957 Review.
Current pharmacotherapy for endometriosis.
Ferrero S, Remorgida V, Venturini PL. Ferrero S, et al. Expert Opin Pharmacother. 2010 May;11(7):1123-34. doi: 10.1517/14656561003685880. Expert Opin Pharmacother. 2010. PMID: 20230308 Review.
Bevacizumab in endometrial cancer treatment.
Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. Morotti M, et al. Among authors: ferrero s. Expert Opin Biol Ther. 2012 May;12(5):649-58. doi: 10.1517/14712598.2012.672558. Epub 2012 Mar 20. Expert Opin Biol Ther. 2012. PMID: 22428875
Monoclonal antibodies therapies for ovarian cancer.
Leone Roberti Maggiore U, Bellati F, Ruscito I, Gasparri ML, Alessandri F, Venturini PL, Ferrero S. Leone Roberti Maggiore U, et al. Among authors: ferrero s. Expert Opin Biol Ther. 2013 May;13(5):739-64. doi: 10.1517/14712598.2013.767328. Epub 2013 Feb 4. Expert Opin Biol Ther. 2013. PMID: 23373587 Review.
[Acute myocardial infarction in pregnancy].
Rosa GM, Bauckneht M, Ferrero S, Leone Roberti Maggiore U, Brunelli C. Rosa GM, et al. Among authors: ferrero s. G Ital Cardiol (Rome). 2013 Feb;14(2):126-34. doi: 10.1714/1218.13525. G Ital Cardiol (Rome). 2013. PMID: 23389315 Review. Italian.
Imidafenacin for the treatment of overactive bladder.
Leone Roberti Maggiore U, Scala C, Venturini PL, Ferrero S. Leone Roberti Maggiore U, et al. Among authors: ferrero s. Expert Opin Pharmacother. 2013 Jul;14(10):1383-97. doi: 10.1517/14656566.2013.796930. Epub 2013 May 6. Expert Opin Pharmacother. 2013. PMID: 23641864 Review.
Cardiovascular effects of antimuscarinic agents in overactive bladder.
Rosa GM, Bauckneht M, Scala C, Tafi E, Leone Roberti Maggiore U, Ferrero S, Brunelli C. Rosa GM, et al. Among authors: ferrero s. Expert Opin Drug Saf. 2013 Nov;12(6):815-27. doi: 10.1517/14740338.2013.813016. Epub 2013 Jun 26. Expert Opin Drug Saf. 2013. PMID: 23800037 Review.
Targeting tyrosine-kinases in ovarian cancer.
Morotti M, Becker CM, Menada MV, Ferrero S. Morotti M, et al. Among authors: ferrero s. Expert Opin Investig Drugs. 2013 Oct;22(10):1265-79. doi: 10.1517/13543784.2013.816282. Epub 2013 Jul 2. Expert Opin Investig Drugs. 2013. PMID: 23815710 Review.
Mirabegron in the treatment of overactive bladder.
Leone Roberti Maggiore U, Cardozo L, Ferrero S, Sileo F, Cola A, Del Deo F, Torella M, Colacurci N, Candiani M, Salvatore S. Leone Roberti Maggiore U, et al. Among authors: ferrero s. Expert Opin Pharmacother. 2014 Apr;15(6):873-87. doi: 10.1517/14656566.2014.898752. Expert Opin Pharmacother. 2014. PMID: 24646053 Review.
944 results